AngioDynamics: NanoKnife Momentum Looks Real, But Much Of The Good News Is Priced In
AngioDynamics Inc ANGO
$14.79
▲ +0.14%
(+$0.02)
Open
$14.75
Prev Close
$14.77
Day Range
$14.59 – $14.93
52W Range
$8.36 – $15.20
Market Cap
$611.31M
Beta
0.30
EPS (TTM)
$-0.89
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2004-05-27 |
| Shares Out. | 41,330,000 |
| Website | angiodynamics.com/ ↗ |
| Phone | 13026587581 |
| Employees | 632 |
| Revenue | $86.6M |
| Gross Profit | $46.8M |
| Net Income | -$11.4M |
| Free Cash Flow | $508,000 |
| Total Assets | $267.2M |
| Total Liabilities | $96.3M |
| Equity | $170.8M |
About AngioDynamics Inc
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
AngioDynamics Inc is a publicly traded company under the ticker symbol ANGO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)